Paloma Partners’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Paloma Partners’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-473,507	Closed	-$1.89M	–	2390
2019 Q4	$1.89M	Buy	473,507 +463,277	+4,529%	+$2.18M	0.03%	618
2019 Q3	$50K	Buy	+10,230	New	+$57.2K	﹤0.01%	1876
2018 Q2	–	Sell	-26,462	Closed	-$533K	–	2409
2018 Q1	$533K	Sell	26,462 -12,040	-31%	-$281K	0.01%	1331
2017 Q4	$773K	Buy	+38,502	New	+$757K	0.01%	1160

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Paloma Partners's DPLO Position: Q1 2020 in Review

Paloma Partners sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 473,507 shares — an estimated $1.89M sold.

Paloma Partners first reported a position in DPLO in Q4 2017 and held it in 4 quarters. The position peaked at $1.89M in Q4 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Paloma Partners reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Paloma Partners sold 473,507 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1.89M.
Paloma Partners first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2017 and held it in 4 quarters.
Paloma Partners's DIPLOMAT PHARMACY, INC. position peaked at $1.89M in Q4 2019.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Paloma Partners's 13F filing for Q1 2020, filed 15 May 2020.